about
New Molecular Insights of Insulin in Diabetic CardiomyopathyInsulin resistance and hyperinsulinaemia in diabetic cardiomyopathyInterplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathyThe impact of growth hormone on proteomic profiles: a review of mouse and adult human studies.Ubiquinol reduces muscle wasting but not fatigue in tumor-bearing miceThe PKD inhibitor CID755673 enhances cardiac function in diabetic db/db miceMuscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet.Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling.Cardiomyocyte GTP Cyclohydrolase 1 Protects the Heart Against Diabetic CardiomyopathyDerangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption.Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice.Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure.Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo.Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.Transplanted bone marrow mesenchymal stem cells protects myocardium by regulating 14-3-3 protein in a rat model of diabetic cardiomyopathyInhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes.Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.The Chinese Herb Yi-Qi-Huo-Xue Protects Cardiomyocyte Function in Diabetic Cardiomyopathy.Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
P2860
Q26752678-DBE6F498-A25D-4913-B67D-FB3734F301C1Q26775037-F76DCE9B-031F-4DD4-A576-D2A0C42FE2C5Q27001165-E579EF2B-5ECF-4AB5-9DA4-45814A0A0369Q33857579-68368B25-5944-49FE-AA70-F76951C0CB45Q35186185-14FE1DA4-FD4D-42EE-BA44-F29C8422645CQ35209408-9812302B-5D78-4AB0-90BF-3552F7B3E6DFQ35716907-C17101B0-7402-4AE6-A207-A765A10273A5Q36267548-1BF64C05-E26F-49A6-87E2-61356D93C902Q36997215-5FC826D4-4030-4973-8215-8BAD07D98F65Q38965115-A5091E8A-651A-4725-A877-5489ABFFDEABQ38982581-6663B7D6-9074-4669-8E5F-C083D0F0CD06Q41297700-49F58FDB-C0B7-4323-9A45-B01BE1F935F2Q41841136-BAA24A44-74F0-4E3A-A62B-4F7BC03E54F8Q42394507-ECEF499C-324D-47DF-8FF0-930F131325EFQ42782935-CD50DE11-2580-45B5-8EEC-147A7192A97EQ49335803-3EF920F3-EB9A-4CF4-9A11-F4E6D3F2270BQ49384661-BD93D490-53EC-4298-8D12-0D532D06E72AQ51596254-69738927-FD59-4036-869C-B6E5042F910AQ55004256-F7690CB7-1C36-49F9-AD32-193D766D7627Q55240593-0A927C27-DFDD-4B9F-85B1-4CF921D331ADQ58698076-036BF7DB-6D33-46C0-976B-01020AC04E17
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Metabolic dysfunction in diabetic cardiomyopathy.
@en
type
label
Metabolic dysfunction in diabetic cardiomyopathy.
@en
prefLabel
Metabolic dysfunction in diabetic cardiomyopathy.
@en
P2093
P2860
P1476
Metabolic dysfunction in diabetic cardiomyopathy.
@en
P2093
Chian Ju Jong
Loren E Wold
Michael Isfort
Sarah C W Stevens
Stephen Schaffer
P2860
P2888
P356
10.1007/S10741-013-9377-8
P577
2014-01-01T00:00:00Z